Nanexa Future Growth
Future criteria checks 0/6
Nanexa's revenue and earnings are forecast to decline at 79.8% and 4% per annum respectively.
Key information
-4.0%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | -79.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 04 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 15 | -40 | N/A | N/A | 1 |
| 12/31/2024 | 71 | 16 | N/A | N/A | 1 |
| 9/30/2024 | 51 | -64 | -52 | -22 | N/A |
| 6/30/2024 | 53 | -67 | -58 | -26 | N/A |
| 3/31/2024 | 60 | -71 | -74 | -37 | N/A |
| 12/31/2023 | 59 | -76 | -77 | -43 | N/A |
| 9/30/2023 | 52 | -43 | -39 | -8 | N/A |
| 6/30/2023 | 47 | -49 | -41 | -8 | N/A |
| 3/31/2023 | 35 | -55 | -46 | -12 | N/A |
| 12/31/2022 | 27 | -59 | -43 | -8 | N/A |
| 9/30/2022 | 24 | -54 | -77 | -43 | N/A |
| 6/30/2022 | 19 | -50 | -74 | -40 | N/A |
| 3/31/2022 | 18 | -42 | -59 | -30 | N/A |
| 12/31/2021 | 18 | -36 | -51 | -25 | N/A |
| 9/30/2021 | 19 | -31 | -64 | -24 | N/A |
| 6/30/2021 | 22 | -27 | -49 | -18 | N/A |
| 3/31/2021 | 22 | -25 | -44 | -18 | N/A |
| 12/31/2020 | 21 | -22 | -38 | -17 | N/A |
| 9/30/2020 | 18 | -19 | -23 | -13 | N/A |
| 6/30/2020 | 13 | -18 | -25 | -14 | N/A |
| 3/31/2020 | 11 | -13 | -18 | -7 | N/A |
| 12/31/2019 | 9 | -13 | -20 | -9 | N/A |
| 9/30/2019 | 7 | -12 | -16 | -9 | N/A |
| 6/30/2019 | 6 | -11 | -15 | -9 | N/A |
| 3/31/2019 | 4 | -12 | -17 | -11 | N/A |
| 12/31/2018 | 4 | -11 | -13 | -7 | N/A |
| 9/30/2018 | 4 | -9 | -13 | -7 | N/A |
| 6/30/2018 | 4 | -9 | N/A | -6 | N/A |
| 3/31/2018 | 4 | -8 | N/A | -7 | N/A |
| 12/31/2017 | 3 | -8 | N/A | -5 | N/A |
| 9/30/2017 | 3 | -8 | N/A | -6 | N/A |
| 6/30/2017 | 2 | -8 | N/A | -6 | N/A |
| 3/31/2017 | 2 | -7 | N/A | -5 | N/A |
| 12/31/2016 | 2 | -6 | N/A | -6 | N/A |
| 9/30/2016 | 2 | -6 | N/A | -4 | N/A |
| 6/30/2016 | 2 | -6 | N/A | -5 | N/A |
| 3/31/2016 | 2 | -5 | N/A | -4 | N/A |
| 12/31/2015 | 2 | -4 | N/A | -3 | N/A |
| 9/30/2015 | 1 | -2 | N/A | -3 | N/A |
| 6/30/2015 | 0 | -2 | N/A | 0 | N/A |
| 3/31/2015 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2014 | N/A | -1 | N/A | 1 | N/A |
| 4/30/2014 | 1 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 40M is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 40M is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 40M is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 40M's revenue is expected to decline over the next 3 years (-79.8% per year).
High Growth Revenue: 40M's revenue is forecast to decline over the next 3 years (-79.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 40M's Return on Equity is forecast to be high in 3 years time